A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness
Dominique Bremond-Gignac,1,2 Riadh Messaoud,3 Sihem Lazreg,4 Claude Speeg-Schatz,5 Didier Renault,6 Frédéric Chiambaretta7,8 On behalf of the Azithromycin Pediatric Study Group 1Ophthalmology Department, Centre St Victor, University Hospital of Amiens, Picardie Jules Verne Un...
Guardado en:
Autores principales: | Bremond-Gignac D, Messaoud R, Lazreg S, Speeg-Schatz C, Renault D, Chiambaretta F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c9487db7a16446fabe99f5e97125d78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution
por: Fernandez KB, et al.
Publicado: (2015) -
Allergic contact dermatitis caused by dorzolamide eyedrops
por: Lee SJ, et al.
Publicado: (2015) -
Bacteria Biofilms in Purulent-Septic Infections
por: E. D. Savilov, et al.
Publicado: (2019) -
Fluoroquinolones compared to 1% azithromycin in DuraSite® for bacterial conjunctivitis [from Lichenstein and Granet] and Response to correspondence [from Friedlaender and Protzko] ||FREE PAPER||
por: Steven J Lichtenstein, et al.
Publicado: (2008) -
LOCAL IMMUNITY PATTERNS IN PURULENT WOUNDS
por: K. V. Shmagel, et al.
Publicado: (2014)